How MedSpas Are Adding Exosome Treatments to Their Service Menu
A practical guide for medspa owners evaluating exosome treatments — what to look for in a supplier, what documentation to demand, and how to position it compliantly.
Exosome treatments are one of the fastest-growing service categories in the medspa industry. Paired with microneedling, laser resurfacing, or as standalone topical facials, they offer a premium service that clients are actively requesting.
But adding exosomes to your menu requires more than buying a product and listing a price. Here's what medspas need to know.
Choose Your Supplier Carefully
The exosome supply market includes everything from established manufacturers to resellers with minimal documentation. Before committing to a supplier, verify: batch-specific independent COA, disclosed tissue source, donor screening per FDA 21 CFR 1271, and batch-level traceability.
Documentation Is Your Liability Shield
When offering exosome treatments, your documentation is your evidence that the product was sourced responsibly. A complete paper trail — independent COA, donor screening, batch traceability — protects you if a regulatory body or accreditor requests proof of product quality.
Positioning Compliantly
No exosome product is FDA-approved for therapeutic use. Compliant positioning frames exosomes as "topical cosmetic products" or "research-grade biomaterials" — never as treatments for specific medical conditions. Your supplier's regulatory posture should match your own.
Pricing Models
Exosome facial treatments typically retail for $300-$800 per session depending on geographic market, product cost, and whether they're paired with microneedling. Product cost to the clinic ranges from $135-$800 per vial depending on concentration and source.